1. Academic Validation
  2. Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators

Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators

  • Nat Struct Mol Biol. 2017 Feb;24(2):108-113. doi: 10.1038/nsmb.3329.
Xin Huang 1 Paul L Shaffer 1 Shawn Ayube 1 Howard Bregman 2 Hao Chen 3 Sonya G Lehto 4 Jason A Luther 5 David J Matson 5 Stefan I McDonough 5 Klaus Michelsen 6 Matthew H Plant 6 Stephen Schneider 5 Jeffrey R Simard 5 Yohannes Teffera 7 Shuyan Yi 2 Maosheng Zhang 4 Erin F DiMauro 2 Jacinthe Gingras 5
Affiliations

Affiliations

  • 1 Department of Molecular Structure and Characterization, Amgen Inc., Cambridge, Massachusetts, USA.
  • 2 Department of Medicinal Chemistry, Amgen Inc., Cambridge, Massachusetts, USA.
  • 3 Department of Protein Technologies, Amgen Inc., Cambridge, Massachusetts, USA.
  • 4 Department of Neuroscience, Amgen Inc., Thousand Oaks, California, USA.
  • 5 Department of Neuroscience, Amgen Inc., Cambridge, Massachusetts, USA.
  • 6 Department of Discovery Attribute Sciences, Amgen Inc., Cambridge, Massachusetts, USA.
  • 7 Department of Pharmacokinetics &Drug Metabolism, Amgen Inc., Cambridge, Massachusetts, USA.
Abstract

Current therapies to treat persistent pain and neuropathic pain are limited by poor efficacy, side effects and risk of addiction. Here, we present a novel class of potent selective, central nervous system (CNS)-penetrant potentiators of glycine receptors (GlyRs), ligand-gated ion channels expressed in the CNS. AM-1488 increased the response to exogenous glycine in mouse spinal cord and significantly reversed mechanical allodynia induced by nerve injury in a mouse model of neuropathic pain. We obtained an X-ray crystal structure of human homopentameric GlyRα3 in complex with AM-3607, a potentiator of the same class with increased potency, and the agonist glycine, at 2.6-Å resolution. AM-3607 binds a novel allosteric site between subunits, which is adjacent to the orthosteric site where glycine binds. Our results provide new insights into the potentiation of cysteine-loop receptors by positive allosteric modulators and hold promise in structure-based design of GlyR modulators for the treatment of neuropathic pain.

Figures
Products